Evidence map›Paper›PMID 39627156›Full record

ArticleRenal failure2024

Exploring the causal effect of complement and IgA nephropathy-a Mendelian randomization study.

Han Xu, Mengxiao Zou, Yichun Cheng, Shuwang Ge

Abstract read
In one paragraph

Article in Renal failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Han XuDepartment of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Mengxiao ZouDepartment of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Yichun ChengDepartment of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Shuwang GeDepartment of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgA nephropathy, one of the most common primary glomerulonephritis worldwide, is still under investigation for its precise etiology. The widely accepted theory is the 'four-hit model' and subsequent complement and inflammatory responses. Recent studies have reported correlations between specific complement components and IgA nephropathy. However, the causal effects of genetically predicted complement components on IgA nephropathy require further elucidation. Our study aimed to determine the causal relationship between genetic predictors of complement and IgA nephropathy using the Mendelian randomization method. The primary analysis was initially conducted, examining heterogeneity and horizontal pleiotropy tests in each subgroup. Complement components with positive results were further analyzed using the MR-PRESSO test and co-localization analysis. Subsequently, the positive results were further analyzed using the cML-MA method to validate the previous studies. Finally, a Bi‑directional analysis was performed, providing a brief evaluation of the causal effect of IgA nephropathy on complement components. We found a causal effect between C1QBP, C3b, C3d, C2, and C7 and IgA nephropathy, but did not identify any reverse causality. Results from co-localization analysis suggest intricate pathway interactions between the complement system and IgA nephropathy. Our findings provide possible directions for subsequent complement research, which will contribute to further exploration of the etiology of IgA nephropathy.

Indexed as

Complement System ProteinsGlomerulonephritis, IGAMendelian Randomization AnalysisGenetic Predisposition to DiseaseHumansPolymorphism, Single NucleotideComplement System ProteinsCo-localization analysisComplementIgA nephropathyMendelian randomization

Identifiers

PMID39627156
PMCPMC11616755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.